Christopher Nishimura

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “TMIGD2 is an orchestrator and therapeutic target on human acute myeloid leukemia stem cells”.

TMIGD2 is an orchestrator and therapeutic target on human acute myeloid leukemia stem cells

Nature Communications(2024)10.1038/s41467-023-43843-6

N/A

0.614DataRank · unranked

59 citations

R. Alejandro Sica, Gurbakhash Kaur, Phillip M. Galbo, Zhixin Jing, Christopher Nishimura +8 more

PD-L1 and B7-1 Cis-Interaction: New Mechanisms in Immune Checkpoints and Immunotherapies

Trends in Molecular Medicine(2020)10.1016/j.molmed.2020.10.004

N/A

0DataRank · unranked

47 citations

Marc C. Pulanco, Wei Cui, Liming Lu, Xingxing Zang, Christopher Nishimura

Crosstalk between the B7/CD28 and EGFR pathways: Mechanisms and therapeutic opportunities

Genes & Diseases(2021)10.1016/j.gendis.2021.08.009

N/A

0DataRank · unranked

23 citations

Yixian Li, Christopher Nishimura, Xingxing Zang, Xiaoxin Ren

A SOX9-B7x axis safeguards dedifferentiated tumor cells from immune surveillance to drive breast cancer progression

Developmental Cell(2023)10.1016/j.devcel.2023.10.010

N/A

0DataRank · unranked

29 citations

Peter John, Kenta Nishitani, Jihong Cui, Christopher Nishimura, John R. Christin +16 more